The Latest on Life Science Innovations

The California Biotechnology Foundation is committed to keeping you up to date about the latest breakthroughs in biotech treatments and the impact of one of California’s largest industries in the state and beyond. This newsletter edition, as of February 25, 2026, brings you updates directly from the forefront of medical innovation. Among the notable advancements featured are:

• UCLA researchers have created a non-viral lipid nanoparticle gene-editing therapy that restores near-normal lung cell function in cystic fibrosis, marking a promising step toward a universal treatment for inherited lung diseases.

• The FDA has approved Optune Pax, a first-of-its-kind wearable device that uses tumor-treating electrical fields alongside standard chemotherapy to slow tumor growth, improve survival and delay pain in adults with locally advanced pancreatic cancer.

• UC Davis researchers are testing “smart” nanoparticles that transform at tumor sites, cling to cancer cells and enable precise, on-demand delivery of therapies while sparing healthy tissue, a promising step toward more effective and less toxic cancer treatment.